检索结果-南通市图书馆

Polypeptide from Moschus Suppresses Lipopolysaccharide-Induced Inflammation by Inhibiting NF-κB-ROS/NLRP3 Pathway

Chinese Journal of Integrative Medicine 2023年第10期29卷 895-904页

作者： YI Jing LI Li YIN Zhu-jun QUAN Yun-yun TAN Rui-rong CHEN Shi-long LANG Ji-rui LI Jiao ZENG Jin LI Yong SUN Zi-jian zhao jun-ning Department of Pharmacology Southwest Medical UniversityLuzhouSichuan Province646000China Sichuan Institute for Translational Chinese Medicine Translational Chinese Medicine Key Laboratory of Sichuan ProvinceSichuan Academy of Chinese Medicine SciencesChengdu610000China Hunan Provincial Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations College of PharmacyChangsha Medical UniversityChangsha410219China Sichuan Fengchun Pharmaceutical Co. Ltd.DeyangSichuan Province618100China Sichuan Ant Recommendation Biotechnology Co. Ltd.Chengdu610000China

Objective To examine the anti-inflammatory effects and potential mechanisms of polypeptide from Moschus(PPM)in lipopolysaccharide(LPS)-induced THP-1 macrophages and BALB/c *** The polypeptide was extracted from Moschus and analyzed by high-performance liquid chromatography and sodium dodecyl sulfate-polyacrylamide gel electrophoresis(SDS-PAGE).Subsequently,LPS was used to induce inflammation in THP-1 macrophages and BALB/c *** LPS-treated or untreated THP-1 macrophages,cell viability was observed by cell counting kit 8 and lactate dehydrogenase release assays;the proinflammatory cytokines and reactive oxygen species(ROS)were measured by enzyme-linked immunosorbent assay and flow cytometry,respectively;and protein and mRNA levels were measured by Western blot and real-time quantitative polymerase chain reaction(qRT-PCR),*** LPS-induced BALB/c mice,the proinflammatory cytokines were measured,and lung histology and cytokines were observed by hematoxylin and eosin(HE)and immunohistochemical(IHC)staining,*** The SDS-PAGE results suggested that the molecular weight of purified PPM was in the range of 10–26 *** vitro,PPM reduced the production of interleukin 1β(IL-1β),IL-18,tumor necrosis factorα(TNF-α),IL-6 and ROS in LPS-induced THP-1 macrophages(Pning 3(NLRP3)inflammasome pathway by reducing protein expression of phospho-NF-κB p65,phospho-inhibitors of NF-κB(IκBs)kinaseα/β(IKKα/β),TXNIP,NLRP3,apoptosis-associated speck-like protein containing a caspase recruitment domain(ASC),and pro-caspase-1(P<0.05 or P<0.01).In addition,qRT-PCR revealed the inhibitory effects of PPM on the mRNA levels of TXNIP,NLRP3,ASC,and caspase-1(P<0.05 or P<0.01).Furthermore,in LPS-induced BALB/c mice,PPM reduced TNF-αand IL

关键词： Moschus polypeptide inflammation NLRP3 inflammasome thioredoxin interacting protein nuclear factorκB Chinese medicine

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Treatment of polycystic liver disease with resection-fenestration and a new classification

引用

World Journal of Gastroenterology 2008年第32期14卷 5066-5072页

作者： Tuan-Jie Li Hai-Bin Zhang jun-Hua Lu jun zhao ning Yang Guang-Shun Yang Eastern Hepatobiliary Hospital Second Military Medical University Shanghai 200438 China

AIM: To evaluate outcomes in patients with autosomal dominant polycyst liver disease (APLD) treated by combined hepatic resection and fenestration. A new classification was recommended to presume postoperative complications and long outcome of patients. METHODS: Twenty-one patients with APLD were treated by a combined hepatic resection and fenestration technique. All patients were reviewed retrospectively, and clinical symptoms, performance status and morbidity were recorded. A new classifi cation of APLD is recommended here. RESULTS: All patients were discharged when free of symptoms. The mean follow-up time was 55.7 mo and three patients had a recurrence of symptoms at 81, 68 and 43 mo after operation, respectively. The overall morbidity rate was 76.2%. Two patients with Type B-Ⅱ and Type B-Ⅰ developed biliary leakage. Four patients had severe ascites, including three with Type B-Ⅲ and one with Type B-Ⅱ, Nine patients had pleural effusion, including one with Type A-Ⅰ; one with Type B-Ⅰ; fi ve with Type B-Ⅱ; one with Type A-Ⅲ and one with Type B-Ⅲ. Three patients with Type B had recurrence of symptoms, while none with Type A had severe complications. CONCLUSION: Combined hepatic resection and fenestration is an acceptable procedure for treatment of APLD. According to our classifi cation, postoperative complications and long outcome can be predicted before surgery.

关键词： Autosomal dominant polycyst liverdisease Autosomal dominant polycyst kidney disease Fenestration

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

中药监管科学:助力更高水平的中药科学监管

引用

中国药学杂志 2023年第9期58卷 749-761页

作者：赵军宁国家药品监督管理局药品监管科学全国重点实验室北京100037

我国的中药监管经历了传统中药质量监管(感官性状鉴别)、现代中药质量监管(理化性质分析)、中药注册标准建立(有效性、安全性与质量控制技术)、中药监管科学行动及科学监管(新工具、新标准、新方法)等制度演进和科学化进程,目前已经进... 详细信息

我国的中药监管经历了传统中药质量监管(感官性状鉴别)、现代中药质量监管(理化性质分析)、中药注册标准建立(有效性、安全性与质量控制技术)、中药监管科学行动及科学监管(新工具、新标准、新方法)等制度演进和科学化进程,目前已经进入全过程审评审批加速、全产业链质量管控、全生命周期技术创新、全球化监管协调的全方位科学监管新阶段。本研究提出中药监管科学(TCM rugulatory science)是基于中药产品特殊的中医和药品“双重”属性,通过中西医药学、监管科学等的跨学科知识、技术融合研究,研发符合中药特点的新工具、新标准和新方法,用以评估受监管的中药材、中药饮片、中成药等中药产品的安全性、有效性、质量和风险获益综合性能的新兴科学,以加速中药新兴技术产品转化和促进中医药传承创新发展。中药监管科学既是监管科学(rugulatory science)在中药监管领域应用的新兴前沿学科,也是中西医融合研究(convergence research)的新策略和新范式。把监管科学和融合科学研究引入中药监管领域,源自国家药监部门肩负的“强化药品安全监管”和“促进中医药传承创新发展”的责任和使命,是药监部门主动适应中医药守正创新、科技发展、产业推动、健康需求、国际竞争新形势所采取的变革性措施。进一步全面强化中药监管科学体系建设,解决中药监管基础性、关键性、前沿性和战略性技术问题,对于建立符合中医药特点的中药审评审批体系和实现更高水平的中药科学监管,加速中药新技术新产品转化应用,造就强大中药产业,促进中医药传承创新至关重要。

关键词：中药药品监督管理中药监管科学融合科学中医药传承创新

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Phosphatase and tensin homolog gene inhibits the effect induced by gonadotropin-releasing hormone subtypes in human endometrial carcinoma cells

引用

Chinese Medical Journal 2010年第9期123卷 1170-1175页

作者： zhao Li-jun LIU ning LI Xiao-ping WANG Jian-liu WEI Li-hui Department of Obstetrics & Gynecology Peking University People's Hospital100044BeijingChina

Background Type I gonadotropin-releasing hormone （GnRH-l） agonists have been applied for the treatment of steroid-dependent tumors such as breast carcinoma, ovarian cancer and prostatic carcinoma. But the mechanism has not been clarified yet. There are few reports about the treatment of endometrial carcinoma using GnRH-l agonists. Type II GnRH （GnRH-ll） is a new subtype of GnRH. Our aim was to investigate the effects of GnRH-l agonists and GnRH-ll on estrogen receptor-negative human endometrial carcinoma cells and the effect from phosphatase and tensin homolog gene （PTEN） to *** A lentiviral vector-mediated RNAi method was used to establish a PTEN-negative HEC-1A cell clone （HEC-1A-ND）. MTT and flow cytometry were used to detect the cell proliferation, cell cycle and apoptosis of HEC-1A, HEC-1A-NC and HEC-1A-ND cells after treatment with GnRH-l agonist Triptorelin （10-11 mol/L to 10-5 mol/L） or GnRH-ll （10-11 mol/L to 10-5 mol/L）. Western blotting was used to detect AKT and ERK1/2 activation after treatment with different concentrations of Triptorelin or GnRH-ll for 30 minutes in the above mentioned three kinds of cells. Results Triptorelin and GnRH-ll induced apoptosis and inhibited proliferation of HEC-1 A, HEC-1A-ND and HEC-1A-NC in a dose-dependent manner. This effect was augmented in HEC-1 A-ND cells in which PTEN gene was knocked-down. Furthermore, Triptorelin and GnRH-ll inhibited the AKT and ERK activity in HEC-1 A-ND *** Triptorelin and GnRH-ll can promote apoptosis rate and inhibit cell proliferation of estrogen receptor-negative endometrial carcinoma cells in a dose-dependent manner. PTEN gene can inhibit the effects of Triptorelin or GnRH-ll on human endometrial carcinoma cells.

关键词： human endometrial carcinoma gonadotropin-releasing hormone-I agonist estrogen receptor

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

A Matched Comparison Study of Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early-stage Nonsmall Cell Lung Cancer

引用

Chinese Medical Journal 2015年第20期128卷 2731-2735页

作者： Ju-Wei Mu Shu-Geng Gao Qi Xue jun zhao ning Li Kun Yang Kai Su Zhu-Yang Yuan Jie He Department of Thoracic Surgery Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100021 China

Background： Both uniportal and triportal thoracoscopic lobectomy and sublobectomy are feasible for early-stage non-small cell lung cancer （NSCLC）. The aim of this study was to compare the perioperative outcomes of uniportal and triportal thoracoscopic Iobectomy and sublobectomy for early-stage NSCLC. Methods： A total of 405 patients with lung lesions underwent thoracoscopic lobectomy or sublobectomy through a uniportal or triportal procedure in approximately 7-month period （From November 2014 to May 2015）. A propensity-matched analysis, incorporating preoperative variables, was used to compare the short-term outcomes of patients who received uniportal or triportal thoracoscopic lobectomy and sublobectomy. Results： Fifty-eight patients underwent uniportal and 347 patients underwent triportal pulmonary resection. The conversion rate for uniportal and triportal procedure was 3.4% （2/58） and 2.3% （8/347）, respectively. The complication rate for uniportal and triportal procedure was 10.3% and 9.5%, respectively. There was no perioperative death in either group. Most patients had early-stage NSCLC in both groups （uniportal： 45/47, 96%; triportal： 313/343, 91%）. Propensity score-matching analysis demonstrated no significant differences in operation time, intraoperative blood loss, numbers of dissected lymph nodes, number of stations of lymph node dissected, duration of chest tube, and complication rate between uniportal and triportal group for early-stage NSCLC. However, the duration of postoperative hospitalization was longer in the uniportal group （6.83 ± 4.17 vs. 5.42 ± 1.86 d, P = 0.036） compared with the triportal group. Conclusions： Uniportal thoracoscopic lobectomy and sublobectomy is safe and feasible, with comparable short-term outcomes with triportal thoracoscopic pulmonary resection. Uniportal lobectomy and sublobectomy lead to similar cure rate as triportal Iobectomy and sublobectomy for early NSCLC.

关键词： Early-stage Nonsmall Cell Lung Cancer Lobectomy Sublobectomy Uniportal Video-assisted Thoracoscopic Surgery

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

In vitro and in vivo anti-HMPV activity of JH001 isolated from Chinese medicinal herbs

引用

中国药理学与毒理学杂志 2021年第10期35卷 733-733页

作者： LI Jin-hua zhao Yao DAI Ying zhao jun-ning West China School of Pharmacy Sichuan University Chengdu 610041China Sichuan Academy of Chinese Medicine Sciences Chengdu 610041China Sichuan Institute for Translational Chinese Medicine Chengdu 610041China Children′s Hospital of Chongqing Medical University Chongqing 400014China

OBJECTIVE Human metapneumovirus(hMPV)is semblable to respiratory syncytial virus(RSV)which causes respiratory infections typically characterized by cough,runny nose,fever,and nasal congestion but sometimes progressing to bronchiolitis and ***,there is no corresponding drug to inhabit the *** of new compounds with potential anti-HMPV activity could produce clinical *** herbal medicine played a great role during COVID-19,therefore we choose some small molecular(JH001)extracted from botany to investigate therapeutic effect on hMPV and the underlying *** In this study,16HBE cells were used as a model to explore in vitro antiviral *** assays were performed before the antiviral tests,cell viability of 16HBE cells handled by different concentration of JH001 was estimated by Cell Counting Kit-8(CCK-8).Then RT-qPCR,immunofluorescence,and flow cytometer were used to test the viral titer after cells infected with ***,6-8 weeks mice were infected intranasally with 60μL of hMPV,the control group was treated with 0.9%saline water,other groups were administered with JH001 and ribavirin,then the lung virus titer and protective effect in lung were *** The obtained JH001 exhibited no cytotoxicity to 16HBE cells during 6.25-200μmol·L^(-1).RT-QPCR demonstrated that JH001 showed obvious inhabitation to the viral replication and showed great significance compared with *** fluorescence exhibited distinct decrease of hMPV-N protein,flow cytometer results showed that MFI decrease *** reduction of N-gene expression was observed in those mice treated with JH001 compared with saline group,which indicated that JH001 probably had protective and therapeutic effect on viral *** This study illustrated that JH001 might be a promising option for small molecular against hMPV and JH001 might be worthy of further development and used as a potential therapeutic strategy for

关键词： human metapneumovirus Chinese herbal medicine antiviral activity respiratory infections

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

具奇性的非线性抛物方程

引用

厦门大学学报（自然科学版） 2001年第2期40卷 163-172页

作者：赵俊宁谭忠厦门大学数学系福建厦门361005

介绍了具奇性的非线性抛物方程解的存在性。

关键词：奇性非线性抛物方程解存在唯一性性质正则性分界面渐近形态

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

基于肿瘤超早期免疫应答信息放大指标naCTL,TCR/BCR/HLA有效多样性等免疫信息学多维指标的中医(肿瘤)治未病测知、评价模型(体系)构建

引用

中国中药杂志 2019年第15期44卷 3129-3134页

作者：张翼冠赵军宁四川省中医药转化医学中心四川省中医药科学院转化药理与临床应用研究所国家中医药管理局中药质量生物评价重点研究室四川省道地药材系统研究工程技术中心中药品质评价及创新中药四川省重点实验室四川成都610041

肿瘤细胞在形成瘤体前(超早期)是干预最佳时期,但限于该时期肿瘤细胞数量,当前主要针对其本身的检测(如CTC,ct DNA等)难以实现肿瘤细胞与免疫力的量化,这不仅无法实现该时期精准预防,也影响中医(肿瘤)治未病深入测知、干预、评价。鉴于... 详细信息

肿瘤细胞在形成瘤体前(超早期)是干预最佳时期,但限于该时期肿瘤细胞数量,当前主要针对其本身的检测(如CTC,ct DNA等)难以实现肿瘤细胞与免疫力的量化,这不仅无法实现该时期精准预防,也影响中医(肿瘤)治未病深入测知、干预、评价。鉴于当前检测局限性,该评价体系转而检测与肿瘤细胞直接相关的、经其激活、增殖至高数量级的肿瘤新生抗原特异性细胞毒性T淋巴细胞(naCTL),免疫组有效性多样性(TCR/BCR/HLA在递呈、识别肿瘤新生抗原上的有效多样性),并引入免疫检查点(check point)、中医病证(治未病)信息等,运用多种数据分析及相关算法,建立免疫正常化多维统计模型。该体系充分放大肿瘤超早期信息,同时,深度融合中医整体观、平衡观思想与扶正祛邪基本治则,为机体免疫正常化及中医(肿瘤)治未病提供量化测知、评价新方法,也为中医证候科学内涵与中药复方药效评价提供新思路,新方法。

关键词：肿瘤抗原特异T细胞免疫组库扶正驱邪治则免疫正常化中医(肿瘤)治未病漏斗式评价

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Prandtl方程整体解的存在惟一性

引用

厦门大学学报（自然科学版） 2006年第3期45卷 436-438页

作者：徐新英赵俊宁厦门大学数学科学学院福建厦门361005

考虑非定常的Prandtl方程U(t,x)=xmU1(t,x),且m≥1,0≤x 详细信息

考虑非定常的Prandtl方程U(t,x)=xmU1(t,x),且m≥1,0≤x

关键词： Prandtl方程整体解

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

基于微小毒性检测的中药注射剂质量波动及安全风险预警研究进展

引用

药学学报 2019年第12期54卷 2189-2194页

作者：鄢良春华桦罗茜赵军宁四川省中医药科学院四川省中医药转化医学中心国家中医药管理局中药质量生物评价重点研究室四川省道地药材系统开发工程技术研究中心中药品质评价与创新中药研究四川省重点实验室四川省中医药管理局中药毒性快速检测实验室

中药注射剂具有成分复杂、批间变异度大以及综合毒性、微小毒性、毒性物质及机制尚不完全清楚等特点,急需在现行的中药注射剂质量控制方法基础上进一步提升对其质量一致性和临床应用风险的防控水平。Microtox(微毒)技术是以一种非致病... 详细信息

中药注射剂具有成分复杂、批间变异度大以及综合毒性、微小毒性、毒性物质及机制尚不完全清楚等特点,急需在现行的中药注射剂质量控制方法基础上进一步提升对其质量一致性和临床应用风险的防控水平。Microtox(微毒)技术是以一种非致病的发光细菌为指示生物,以其发光强度的变化为指标,测定环境中有害有毒物质的一种简单、快速的生物毒性检测手段。基于生物检定原理和原则,本文对Microtox技术应用于中药注射剂微小毒性检测的原则、内容、应用等进行了系统研究和综述,以期作为一种新的生物活性检定方法用于中药注射剂的质量波动检测及安全风险预警,提高中药注射剂质量控制的可靠性。

关键词：中药注射剂微小毒性 Microtox技术质量波动风险预警

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：